We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+6.84%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.79B
AUM Growth
-$153M
Cap. Flow
-$217M
Cap. Flow %
-12.08%
Top 10 Hldgs %
46.91%
Holding
72
New
23
Increased
11
Reduced
17
Closed
20

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$129M
2
PFE icon
Pfizer
PFE
+$97.3M
3
BHC icon
Bausch Health
BHC
+$87.4M
4
KEYS icon
Keysight
KEYS
+$66.8M
5
ILMN icon
Illumina
ILMN
+$63.4M

Top Sells

Rank Stock Value
1
MDRX
Veradigm Inc. Common Stock
MDRX
+$96.7M
2
WMGI
Wright Medical Group Inc
WMGI
+$95.4M
3
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$73M
4
ISRG icon
Intuitive Surgical
ISRG
+$69.4M
5
DHR icon
Danaher
DHR
+$68.4M

Sector Composition

Rank Sector Weight
1 Healthcare 71.97%
2 Technology 3.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLCM
51
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$935K 0.05%
+4,059
New +$870K
CEMP
52
DELISTED
Cempra, Inc.
CEMP
$268K 0.01%
+11,408
New +$170K
BIIB icon
53
Biogen
BIIB
$30B
– –
-200,000
Closed -$66.2M
HCA icon
54
HCA Healthcare
HCA
$87.2B
– –
-625,000
Closed -$44.1M
RGLS
55
DELISTED
Regulus Therapeutics
RGLS
– –
-12,917
Closed -$10.6M
SPY icon
56
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-400,000
Closed -$78.8M
VRTX icon
57
CALL
Vertex Pharmaceuticals
VRTX
$121B
– –
-350,000
Closed -$39.3M
XOMA
58
CALL
DELISTED
Xoma
XOMA
– –
-50,000
Closed -$4.21M
VIRX
59
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-2,536
Closed -$3.8M
MDRX
60
DELISTED
Veradigm Inc. Common Stock
MDRX
– –
-7,210,000
Closed -$96.7M
CSII
61
DELISTED
Cardiovascular Systems, Inc.
CSII
– –
-167,900
Closed -$3.97M
AERI
62
DELISTED
Aerie Pharmaceuticals
AERI
– –
-75,000
Closed -$1.55M
WMGI
63
DELISTED
Wright Medical Group Inc
WMGI
– –
-3,150,000
Closed -$95.4M
AGN
64
CALL
DELISTED
Allergan plc
AGN
– –
-200,000
Closed -$48.3M
AGN
65
DELISTED
Allergan plc
AGN
– –
-150,000
Closed -$36.2M
ARIA
66
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-2,365,000
Closed -$12.8M
AEGR
67
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-463,700
Closed -$15.5M
CTRX
68
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
– –
-1,500,000
Closed -$63.2M
NPSP
69
CALL
DELISTED
NPS PHARMACEUTICALS INC
NPSP
– –
-400,000
Closed -$10.4M
CBST
70
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
– –
-1,100,000
Closed -$73M
AGN
71
DELISTED
Allergan Inc
AGN
– –
-250,300
Closed -$44.6M
1 2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q4 2014 Portfolio in Review

As of Q4 2014, HealthCor Management held 72 positions worth $1.79B, down 7.9% from $1.95B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

HealthCor Management withdrew a net $217M in Q4 2014, closing 20 positions and reducing 17 holdings. Its most notable exit was Veradigm Inc. Common Stock, an estimated $96.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 64% a quarter earlier, followed by Technology.

Against the trend, HealthCor Management opened a new position in Gilead Sciences worth $118M.

  • HealthCor Management's largest Q4 2014 buy was Gilead Sciences: 1,250,000 shares worth $118M.
  • HealthCor Management added most to Thermo Fisher Scientific in Q4 2014, an estimated $41.9M increase.
  • HealthCor Management's biggest Q4 2014 reduction was Intuitive Surgical, cutting an estimated $69.4M.
  • HealthCor Management fully exited Veradigm Inc. Common Stock in Q4 2014, selling an estimated $96.7M.
  • HealthCor Management's ten largest holdings make up 47% of its $1.79B portfolio in Q4 2014.
  • HealthCor Management opened 23 new positions and closed 20 in Q4 2014.
  • HealthCor Management's portfolio value fell 7.9% quarter-over-quarter to $1.79B.

Based on HealthCor Management's 13F filing for Q4 2014, filed 17 Feb 2015.